Consolidated Statement of Operations - USD ($)	3 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Details
Revenues	$ 1,511,664	$ 1,697,921
Operating expenses
Cost of revenues	789,916	569,673
Research and development expenses	67,871	47,632
Selling, general, and administrative expenses	817,252	678,819
Operating Expenses	1,675,039	1,296,124
Income/(Loss) from operations	(163,375)	401,797
Interest expense - related party	266,400	266,400
Income/(Loss) before income taxes	(429,775)	135,397
Provision for income taxes	0	0
Net Income/(Loss)	$ (429,775)	$ 135,397
Net income/(loss) per common share - basic	$ (0.06)	$ 0.02
Net income/(loss) per common share - diluted	$ (0.06)	$ 0.02
Weighted average number of common shares outstanding - basic	7,712,091	7,712,091
Weighted average number of common shares outstanding - diluted	7,712,091	7,712,091